Form Type: 4

SEC EDGAR Link
Accession Number:0001562180-21-004397
Date:2021-06-17
Issuer: G1 THERAPEUTICS, INC. (GTHX)
Original Submission Date:

Reporting Person:

SCHWALM CYNTHIA
700 PARK OFFICES DRIVE, SUITE 200
RESEARCH TRIANGLE PARK, NC 27709

Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
Title of SecurityTransaction Date2a. Deemed Execution Date Transaction CodeSharesAcquired or DisposedPrice per share 5. Amount of Securities Beneficially Owned Following Reported Transaction 6. Ownership Form Direct or IndirectNature of Indirect Ownership
COMMON STOCK 2021-06-17 A 4,389 a $0.00 5,889 direct
Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, convertible securities
Title of Derivative Security Conversion or Exercise Price of Derivative Security Transaction Date Deemed Execution Date Transaction Code Number of Derivative Securities Acquired (A) or Disposed of (D) Date ExercisableExpiration Date Title and Amount of Securities Underlying Derivative Security Price of Derivative Security Number of derivative Securities Beneficially Owned Following Reported Transaction(s) Ownership Form: Direct (D) or Indirect (I) Nature of Indirect Beneficial Ownership
STOCK OPTIONS (RIGHT TO BUY) 21.97 2021-06-17 deemed execution date A 19,620 (a) 2031-06-17 common stock 19,620 $21.97 19,620 direct
Footnotes
IDfootnote
f1 represents a restricted stock unit ("rsu") award that vests in its entirety twelve months after june 17, 2021, subject to the reporting person's continued service as a director.
f2 each rsu represents a contingent right to receive one share of issuer common stock
f3 represents 1,500 shares of common stock and 4,389 restricted stock units
f4 the shares underlying this option will vest in their entirety twelve months after june 17, 2021, subject to the reporting person's continued service as a director.
WhaleWisdom Logo

Elevate your investments